ASKA Pharmaceutical Holdings CO., Ltd.
4886 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区芝浦二丁目５番１号
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ASKA Pharmaceutical Holdings Co., Ltd. is a prominent Japanese pharmaceutical company that transitioned to a holding company structure in April 2021, forming the ASKA Pharmaceutical Group. The company focuses on the development and commercialization of innovative pharmaceuticals, including prescription medications and healthcare products. ASKA is dedicated to advancing drug discovery and improving therapeutic options, as evidenced by its ongoing clinical trials and recent product launches, such as the oral contraceptive Slinda® 28. Committed to sustainability, ASKA also plans to open a ZEB certified community center. With a strong emphasis on research and community health, ASKA Pharmaceutical Holdings is poised to contribute significantly to the health and wellness sector in Japan and beyond.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for ASKA Pharmaceutical Holdings CO., Ltd..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 08:15 |
Regulatory News Service
臨時報告書
|
Japanese | 31.4 KB | |
| 2025-06-20 08:11 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2025-06-20 08:10 |
Regulatory News Service
内部統制報告書－第4期(2024/04/01－2025/03/31)
|
Japanese | 28.7 KB | |
| 2025-06-20 08:08 |
Annual Report
有価証券報告書－第4期(2024/04/01－2025/03/31)
|
Japanese | 1.4 MB | |
| 2025-02-07 07:41 |
Regulatory News Service
臨時報告書
|
Japanese | 21.4 KB | |
| 2024-11-08 07:04 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-11-08 07:02 |
Interim Report
半期報告書－第4期(2024/04/01－2025/03/31)
|
Japanese | 183.3 KB | |
| 2024-06-28 07:12 |
Regulatory News Service
臨時報告書
|
Japanese | 22.0 KB | |
| 2024-06-25 06:40 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-06-25 06:39 |
Regulatory News Service
内部統制報告書－第3期(2023/04/01－2024/03/31)
|
Japanese | 23.6 KB | |
| 2024-06-25 06:37 |
Annual Report
有価証券報告書－第3期(2023/04/01－2024/03/31)
|
Japanese | 1.3 MB | |
| 2024-02-09 07:07 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-02-09 07:05 |
Quarterly Report
四半期報告書－第3期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 155.2 KB | |
| 2023-11-10 07:23 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2023-11-10 07:18 |
Quarterly Report
四半期報告書－第3期第2四半期(2023/07/01－2023/09/30)
|
Japanese | 183.9 KB |
Automate Your Workflow. Get a real-time feed of all ASKA Pharmaceutical Holdings CO., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ASKA Pharmaceutical Holdings CO., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
